Announcements Trials
Browse Landscape

Phase

Phase NA 11Phase 4 3Phase 2 2Phase 3 1Phase 1/2 1Phase 1 1

Status

Unknown 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 3Thoracic 1

Conditions

Melanoma 3Breast Neoplasms 2Thymic aplasia 1Small Cell Lung Carcinoma 1Pain, Postoperative 1Neoplasms 1Lung Neoplasms 1Immunologic Deficiency Syndromes 1Hematologic Neoplasms 1Esophageal Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Nivolumab 5aldesleukin 3Ipilimumab 3Blood Specimen Collection 3relatlimab 2Vemurafenib 2Immune Checkpoint Inhibitors 2trametinib 1technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1technetium Tc 99m nanocolloid 1sargramostim 1pembrolizumab 1pasireotide 1encorafenib 1dabrafenib 1binimetinib 1Vindesine 1Standard of Care 1Specimen Handling 1Sevoflurane 1Propofol 1Pharmaceutical Preparations 1Patient-Specific Modeling 1Isoflurane 1Interleukins 1Interleukin-2 1Granulocyte-Macrophage Colony-Stimulating Factor 1Fibrin Tissue Adhesive 1Etanercept 1Desflurane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Melanoma × Blood Specimen Collection × Clear all
NCT02626065 2025-09-15

PAIR

Hospices Civils de Lyon

Phase 4 Completed
32 enrolled
Dermatologic

Melanoma

NCT03313544 2023-04-21

Evolution of the Heart Function When Monitoring Immunotherapies Anti-cancerous Inhibiting PD-1

Assistance Publique Hopitaux De Marseille

Phase 4 Unknown
50 enrolled
DermatologicThoracic

Lung Neoplasms, Melanoma

NCT02068196 2023-03-24

Ipi4

Oslo University Hospital

Phase 4 Active not recruiting
150 enrolled
Dermatologic

Melanoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡